Oyster Point Pharma, Inc. announced the appointment of a new Director and Chairperson to its Board of Directors. The Oyster Point Pharma Board of Directors announced the appointment of Donald Santel as non-executive Chairperson and a Director of the Company and a member of the Compensation Committee. Don joined the Board on July 30, 2021, and will take over as Chairperson as Ali Behbahani, M.D. steps down as Chairperson, remaining a Director of the company.